Podcasts about meningioma

States rush to ban food dyes ahead of federal action; NIH cuts funds for studies of vaccine hesitancy; RFK Jr. ridiculed for urging vitamin A for measles; Brain tumors in firefighters show signature of chemical exposure; Unpacking the causes of numbness, tingling and pain in lower extremities; Class-action lawsuit targets Depo-Provera as contributor to meningioma brain tumors; Uncovering the mystery of Trump's 20+ pound weight loss; Microplastics implicated in spiraling antibiotic resistance.

In this episode of Brain Tumor Talk, we dive into the world of biomarker testing—a powerful tool in brain tumor diagnosis and treatment. With the 2021 World Health Organization (WHO) classification emphasizing the role of molecular biomarkers, understanding tumor profiling is more crucial than ever. Shwetal Mehta, PhD, and Charuta Furey, MD, join us on the episode to break down the science in an accessible way that empowers patients.Tune in to learn the essentials, so you're ready to discuss biomarker testing with your care team.Learn more: https://www.ivybraintumorcenter.org/Follow Ivy Brain Tumor Center on Social: Instagram | Facebook | Twitter | LinkedInSign up for our monthly newsletter to stay informed about the latest in brain tumor research, treatment and community events.Request a No-Cost Clinical Trial Screening: https://www.ivybraintumorcenter.org/brain-tumor-clinical-trials/trialeligibility/ The information shared on this podcast is for educational and informational purposes only and serves as a starting point for you to have a conversation with your personal healthcare provider. Nothing stated on this podcast should be considered medical advice. You should always consult your personal physician or healthcare provider regarding your specific health concerns before beginning or changing any treatment plan. The views, opinions, and positions expressed by the host and guests on this podcast are theirs alone and do not necessarily reflect the views, opinions or positions of th...

Dr. Evan Noch interviews Drs. Nathan Leclair, David Raleigh and Olga Anczukow about their recent manuscript entitled: "RNA splicing as a biomarker and phenotypic driver of meningioma DNA methylation groups", published online in Neuro-Oncology in August 2024.  

Makenna Thomas had a back that was painful, a right arm that turned numb, and  fingers that she could not move, when she was diagnosed with Meningioma of the Spine in early 2018 at the age of 14. Makenna will talk about her battle both physically and even more so emotionally during that period and even beyond, and will also talk about her very successful recovery and life in which she is a senior at UCLA, is the President of the American Cancer Society on campus, oversees the Relay For Life Team at UCLA which is the leading fundraising college in the country for that event, and is studying neuroscience. 

Join us on "Brain Tumor Talk" as we sit down with Dr. Yoshie Umemura, Chief Medical Officer at the Ivy Brain Tumor Center, to dive into the complexities of brain tumor treatments. Dr. Umemura shares her expert insights on everything from the current standard of care and various chemotherapy protocols to the potential life-changing impact of clinical trials.In this episode, Dr. Umemura explains the array of available treatment options, including surgery, radiation, and clinical trials that offer new therapies not yet widely accessible. She emphasizes the importance of a strong patient-doctor partnership, guiding listeners on how to engage with their healthcare providers to make informed decisions tailored to their unique care needs.Discover why clinical trials are pivotal in advancing treatment and how they provide access to groundbreaking therapies while still maintaining quality of life during treatment. Learn what motivates Dr. Umemura to push the boundaries of conventional treatment and get a personal glimpse into her journey to becoming a leading neuro-oncologist.Learn more: https://www.ivybraintumorcenter.org/Follow Ivy Brain Tumor Center on Social: Instagram | Facebook | Twitter | LinkedInSign up for our monthly newsletter to stay informed about the latest in brain tumor research, treatment and community events.Request a No-Cost Clinical Trial Screening: https://www.ivybraintumorcenter.org/brain-tumor-clinical-trials/trialeligibility/ The information shared on this podcast is for educational and informational purposes only and serves as a starting point for you to have a conversation with your personal healthcare provider. Nothing stated on this podcast should be considered medical advice. You should always consult your personal physician or healthcare provider regarding your specific health concerns before beginning or changing any treatment plan. The views, opinions, and positions expressed by the host and guests on this podcast are theirs alone and do not necessarily reflect the views, opinions or positions of th...

Join us for the first episode of "Brain Tumor Talk" where we delve into the complexities of brain tumors with Dr. Nader Sanai, Director of the Ivy Brain Tumor Center and Chief of Neurosurgical Oncology at Barrow Neurological Institute. With over 1,300 brain tumor surgeries conducted annually, Barrow is one of the most active brain tumor treatment facilities in the U.S.In this episode, Dr. Sanai breaks down the basics of brain tumors, discussing their diverse types and the symptoms they can present. He explores why brain tumors are among the most complex and treatment-resistant cancers, highlighting the unique challenges they pose in finding effective treatments.You'll also learn about the latest advancements in brain tumor therapy, the critical role of clinical trials, and the ongoing efforts to develop new, more effective, and less toxic treatment options. Dr. Sanai shares his personal motivation for pursuing a career in neurosurgery and his persistent hope in the face of daunting challenges.Tune in to gain valuable insights into brain tumor care, understand the importance of drug development in oncology, and hear Dr. Sanai's inspiring vision for the future of brain tumor treatment. This episode is a must-listen for patients, caregivers, and anyone interested in the forefront of cancer research.Learn more: https://www.ivybraintumorcenter.org/Follow Ivy Brain Tumor Center on Social: Instagram | Facebook | Twitter | LinkedInSign up for our monthly newsletter to stay informed about the latest in brain tumor research, treatment and community events.Request a No-Cost Clinical Trial Screening: https://www.ivybraintumorcenter.org/brain-tumor-clinical-trials/trialeligibility/ The information shared on this podcast is for educational and informational purposes only and serves as a starting point for you to have a conversation with your personal healthcare provider. Nothing stated on this podcast should be considered medical advice. You should always consult your personal physician or healthcare provider regarding your specific health concerns before beginning or changing any treatment plan. The views, opinions, and positions expressed by the host and guests on this podcast are theirs alone and do not necessarily reflect the views, opinions or positions of th...

In this week's episode, Brain & Life Podcast host Dr. Katy Peters and actor Craig Russell discuss his brain tumor story. He shares the symptoms he experienced that lead him to see a doctor, the process of scheduling his meningioma removal surgery, and his return to work with the support of his family and friends. Then, neurosurgeon Dr. Jonathan Sherman discusses management plans for meningiomas that include Artificial Intelligence and how he ensures patients feel like a “part of the team” throughout the treatment process.   Additional Resources How My Robotic Brain Surgery Resembled Space Travel Different, But the Same Surgery: What to Expect and How to Prepare   Other Brain & Life Podcast Episodes on These Topics BMX Athlete Josh Perry's Perseverance Living with Brain Tumors We want to hear from you! Have a question or want to hear a topic featured on the Brain & Life Podcast? ·       Record a voicemail at 612-928-6206 ·       Email us at BLpodcast@brainandlife.org   Social Media:   Guests: Craig Russell @russandchips Hosts: Dr. Daniel Correa @neurodrcorrea; Dr. Katy Peters @KatyPetersMDPhD

Scientists have recently found a highly accurate way to predict the best treatment for patients with meningioma based on patterns of gene expression in their tumors. In this Better Edge podcast episode, Stephen Magill, MD, PhD, of Northwestern Medicine Neurological Surgery, discusses this innovative test that could change treatment for one in three patients with meningioma.

December 2023 Journal Club Podcast This podcast features two journal articles. Titles: -International Tuberculum Sellae Meningioma Study: Surgical Outcomes and Management Trends -International Tuberculum Sellae Meningioma Study: Preoperative Grading Scale to Predict Outcomes and Propensity Matched Outcomes by Endonasal vs Transcranial Approach To read journal articles: https://journals.lww.com/neurosurgery/fulltext/2023/12000/international_tuberculum_sellae_meningioma_study_.8.aspx https://journals.lww.com/neurosurgery/fulltext/2023/12000/international_tuberculum_sellae_meningioma_study_.9.aspx Author: Stephen T. Magill, MD, PhD Guest faculty: Wenya Linda Bi, MD, PhD Moderator: Jeffrey I. Traylor, MD Co-chair: Rafael A. Vega, MD, PhD

Dr Sanai discusses the prevalence and grading of malignant meningiomas; common symptoms associated with these tumors; treatment modalities for high-grade disease; and more.

In this special episode, Dr. Reena Thomas, neuro-oncologist and clinical associate professor at Stanford Medicine, joins as a guest co-host to talk with former professional BMX athlete now personal coach Josh Perry. Josh shares his experience of being diagnosed with brain tumors known as meningiomas, the surgeries that he has undergone to treat them, and how he moves forward by talking about his experience with others. Next, Dr. Thomas speaks with Dr. Michelle Monje, pediatric neuro-oncologist and professor of neurology, of neurosurgery, of pediatrics, of pathology and of psychiatry at Stanford Medicine. Dr. Monje explains the role of a neuro-oncologist, what a meningioma is, and the different phases involved in clinical trials. Additional Resources  Learn more about brain tumors Brain & Life Podcast: Lawyer, Model Victoria Vesce Uses Her Platform for Brain Tumor Advocacy  Brain & Life: Expert Tips for Navigating Special Events with a Neurologic Condition  Brain & Life Podcast: Switching Roles: A Neuro-oncologist Reflects on his Own Experience with a Brain Tumor We want to hear from you!  Have a question or want to hear a topic featured on the Brain & Life Podcast?  Record a voicemail at 612-928-6206  Email us at BLpodcast@brainandlife.org  Social Media:    Guest: Josh Perry @JoshPerryBMX (Instagram) Josh Perry (LinkedIn); Dr. Michelle Monje @michelle_monje (Twitter)   Hosts: Dr. Daniel Correa @neurodrcorrea; Dr. Reena Thomas of @Stanford_Neuro

In this episode, we review the high-yield topic of Meningioma ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Oncology section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets

Case-based workup and management of Meningioma. Featuring guest Dr Matthew Farrell.

This week we will discuss both Meningioma & Hemiplegia.  ​Our guest today is Marjorie Turner Hollman, a freelance writer/ editor who loves the outdoors, uses hiking poles to help keep her balance on the trail, and has completed four books in the Easy Walks guide book series. Her latest book, My Liturgy of Easy Walks, is a memoir, meditations on learning to live with a changed life. A native Floridian, she came north for college and snow! She has appeared on Boston's ABC news show, Chronicle; Boston's CBS Channel 4; the Boston Globe; local radio and cable TV shows; and been published in local, regional, and national publications.  A meningioma is just one of the more than 120 types of tumors that can occur in the brain. Meningiomas occur when cells from the membrane covering the brain and spinal cord (called the meninges) grow and multiply out of control. These primary tumors are different from metastatic brain tumors, in which cancerous cells travel from other sites, such as the breast or lung, to the brain. Meningiomas usually occur in people aged 40 to 70 and are more common in women than men. About 3% of people over age 60 develop meningioma. ​Meningiomas fall into three general types: benign, atypical and malignant. About 85-90% of meningiomas are truly benign, although they may grow inside the head and cause problems by pressing on the brain. Atypical meningiomas are more difficult to eliminate by surgery alone and may recur locally after treatment. Malignant meningiomas, while uncommon, behave like a cancer and can spread directly into the brain, causing serious neurologic symptoms. (credits: Rosewell Park Cancer Center) ​Unfortunately for Marjorie, the surgery to remove the life-threatening mass growing in her brain caused paralysis to her right side.  She knew before going into surgery she might not survive the 12 hour operation.  What she didn't know, was there was the risk of paralysis.  Her story is one of strength and determination as she took her new condition to task and started helping others with mobility difficulties have a better understanding of accessible hiking trails on the East Coast.   Marjorie Turner Hollman Finding Easy Walks Wherever You Are Freelance Writer/Author/Editor www.marjorieturner.com marjorie@marjorieturner.com https://www.amazon.com/author/marjorieturnerhollman  

Nadia Cestele"Sepolto nell'oblio"Calibano Editorehttps://calibanoeditore.comSenza un passato, anche il presente è incerto.Una donna, quando si sveglia dopo un'operazione al cervello per l'asportazione di un meningioma, non ricorda più nulla del suo passato. Si ritrova smarrita nella vita precedente, accanto alle persone che aveva amato ma che ora non riconosce più. Un incubo dal quale potrebbe uscire costruendosi una nuova realtà, se persone e fatti inquietanti non riemergessero dal suo passato, fino a farle rischiare la vita.Un'insolita indagine psicologica che cresce piano piano ed esplode nell'imprevedibile finale.Una donna si risveglia in una vita di cui non sa riconoscere né i contorni, né gli attori.Così comincia:Martedì, 15 gennaio 2002Non lo so per certo, ma penso di non essere mai stata una donna semplice. Ho la sensazione di essermi costruita una per- sonalità in modo rocambolesco. Sarà quello che chiamano kar- ma, fatto sta che continuo a ritrovarmi in situazioni assurde con una frequenza così alta da farmi pensare che sia sempre stato così. Lo “sento”. Voglio dire, mi sembra famigliare questo muovermi nel mondo. Sento e non ne posso essere certa, visto che ho subito da poco un'operazione al cervello, durante la quale mi hanno ri- mosso un tumore e tutti i ricordi autobiografici. Mi sono svegliata nuova. Senza ricordi e con un marito e un figlio di cinque mesi. Non ricordavo niente e nessuno. È stato come nascere ma nascere adulta, con una coscienza e una conoscenza.Nadia Cestele è nata nel 1972 a Como e vive in provincia di Bologna. Ha pubblicato i romanzi Un passato da dimenticare (Calibano, 2021), La veglia (Calibano, 2022) anch'essi ambientati sulle sponde del Lago di Como, dove l'autrice ha vissuto fino al 1995, e Sepolto nell'oblio (Calibano, 2022).IL POSTO DELLE PAROLEAscoltare fa Pensarehttps://ilpostodelleparole.it

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2022.12.20.521068v1?rss=1 Authors: Brabec, J., Friedjungova, M., Vasata, D., Englund, E., Bengzon, J., Knutsson, L., Szczepankiewicz, F., Sundgren, P. C., Nilsson, M. Abstract: Background: Mean diffusivity (MD) and fractional anisotropy (FA) obtained with diffusion MRI (dMRI) have been associated with cell density and tissue anisotropy across tumors, but it is unknown whether these associations persist at the microscopic level. Purpose: To quantify the degree to which cell density (CD) and structure anisotropy (SA), as determined from histology, account for the intra-tumor variability of MD and FA in meningioma tumors. Furthermore, to clarify whether histological features other than cell density account for additional intra-tumor variability of MD. Materials and Methods: We performed ex-vivo dMRI at 200 m isotropic resolution and histological imaging on 16 excised meningioma tumor samples. Diffusion tensor imaging (DTI) was used to map MD and FA, as well as the in-plane FA (FAIP). Histology images were analyzed in terms of cell nuclei density and structure anisotropy (obtained from structure tensor analysis) and were used separately in a regression analysis to predict MD and FAIP, respectively. A convolutional neural network (CNN) was also trained to predict the dMRI maps from histology patches. The association between MRI and histology was analyzed in terms of coefficient of determination (R2). Regions showing unexplained variance (large residuals) were analyzed to identify features apart from cell density and structure anisotropy that could influence MD and FAIP. Results: Cell density assessed by histology poorly explained intra-tumor variability at the mesoscopic level (200 m) in MD (median R2 = 0.06, interquartile range 0.01 - 0.29) or FAIP (median R2 = 0.19, 0.09 - 0.29). Samples with low R2 for FAIP exhibited low variations throughout the samples and thus low explainable variability, however, this was not the case for MD. Across tumors, cell density and structure anisotropy were associated with MD (R2 = 0.58) and FAIP (R2 = 0.82), respectively. In 37% of the samples (6 out of 16), cell density did not explain intra-tumor variability of MD when compared to the degree explained by the CNN. Tumor vascularization, psammoma bodies, microcysts, and tissue cohesivity were associated with bias in MD prediction when solely CD was considered. Our results support that FAIP is high in the presence of elongated and aligned cell structures, but low otherwise. Conclusion: Cell density and structure anisotropy account for variability in MD and FAIP across tumors but cell density does not explain MD variations within the tumor, which means that low or high values of MD locally may not always reflect high or low tumor cell density. Features beyond cell density need to be considered when interpreting MD. Copy rights belong to original authors. Visit the link for more info Podcast created by Paper Player, LLC

Você já ouviu falar em Meningioma Cerebral? Trata-se de um dos tumores mais comuns do sistema nervoso central Como o nome sugere, o Meningioma surge das meninges, membranas que envolvem o cérebro e a medula. Para falar sobre o tema o âncora Jota Batista entrevista o médico neurocirurgião, Francisco Vaz.

Episode 1950: Our random article of the day is Malignant meningioma.

In this episode, we talk to Rob, diagnosed with a grade 2 glioma, and Carly, with a grade 2 oligodendroglioma, about what it's like to have a craniotomy.  Both  Rob and Carly had an awake craniotomy while Andy who has a grade 2 meningioma had a craniotomy under a general anaestheticThey share their experiences and things they found helpful.You can find out more about craniotomies hereYou can read more about Meningioma's here,  oligodendroglioma here and glioma's hereIf you would like to talk to a member of the support team you can call 0808 800 0004 or email support@thebraintumourcharity.org

Dr. Jasmin Jo interviews Dr. Leland Rogers about his and his team's recent manuscript entitled: "Low-risk meningioma: initial outcomes from NRG Oncology/RTOG 0539", published online in Neuro-Oncology in June 2022 Full Article

Meningiomas can be hard to diagnose because they often grow slowly and it can take years for the onset of symptoms to occur. In this episode, Stephen T. Magill, MD, PhD, talks about how advances in meningioma classification have improved recurrence predictions and potential therapeutic targets. Dr. Magill, an assistant professor of Neurological Surgery at Northwestern Medicine, specializes in surgical neuro-oncology, and his research focuses on meningioma biology and patient outcomes.

Dr. Nicholas Butowski interviews Drs. Sandro Santagata and Wenya Linda Bi about their recent manuscript entitled: "A molecularly integrated grade for meningioma", published online in Neuro-Oncology in September 2021.

This week's case is super unique: Dr. Manisha Geiger walks us through how she rehabbed a patient's vision following a brain meningioma!  There are so many wonderful lessons in this case, but the take home is to never let expectations limit your therapy! Find Dr. Geiger here:Optimum Vision and Eye care (optimumvisionaz.com)_______________________________________________________________________________This episode is brought to you by Lumenis; check their website out hereFollow us @ Visionismorethan2020@twinforksoptometryFacebookInstagramJoin our private facebook group: Vision is More Than 20/20

Meningioma is the most common intracranial tumor, with limited treatment options. In order to identify new therapies for meningioma, it is important to understand their underlying biology. In this Share Your Research talk, Dr. Abrar Choudhury describes his thesis research, which began by looking at DNA methylation patterns to better understand gene regulation in meningioma, leading him to identify the cell cycle proteins CDK4 and CDK6 as therapeutic targets.

Meningioma is the most common intracranial tumor, with limited treatment options. In order to identify new therapies for meningioma, it is important to understand their underlying biology. In this Share Your Research talk, Dr. Abrar Choudhury describes his thesis research, which began by looking at DNA methylation patterns to better understand gene regulation in meningioma, leading him to identify the cell cycle proteins CDK4 and CDK6 as therapeutic targets.

Dr. Maya Graham interviews Drs. Ghazaleh Tabatabai and Felix Behling about their paper entitled “H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort” published online in Neuro-Oncology in December 2020.

Meningioma is a common type of skull base tumor and typically non-cancerous. However, they can still cause symptoms depending on their location and how they grow. Neurosurgeon Dr. William Couldwell explains whether or not a patient should undergo surgery to remove a meningioma and what to expect with the procedure.

Join us for a quick listen of my dear friend Julie Hubert as she speaks to her journey and experience navigating the healthy and unhealthy tendencies of an Enneagram 2 (also referred to as The Helper). In Episode 5 we discuss how asking for help, and receiving help can be difficult. Julie shares her own experience, and what she has learned from the 2's perspective.This insightful bonus content is part of our 2 part series as I share my story of December, and specifically my struggle and survival with a brain tumor in 2011. You can listen to the full story in Episodes 4&5.

Finishing up a two part series (go listen to Episode 4), I share more about my December story specifically related to surviving a large meningioma brain tumor 9 years ago. It was a serious, pivotal time for my family and I, and as such, there are many reflections during this month. There are so many take aways (like never wasting a moment, or having deep gratitude for all things, and countless more!), but one that continuously sifts to the top is the recognition of help. Being helped, helping, asking for help..you name it. During that time of need in our lives, we absolutely were the recipients of help-but it didn't come without hesitation. Why? What are the reasons that keep us from asking? My story may relate to some, but certainly, as we live through a pandemic we all have been in a place of need..AND ALSO, a place of helping and serving those in need. I asked two incredibly insightful helpers (and also dear, loved ones to me), Jake and Julie Hubert to join me in a round table discussion as we chat about my story-and each other's experiences with being helpers and receiving care. Listen in as we discover the power in being loved, being seen, and being connected through the act of service. You'll resonate, I am sure of it.Bonus: Give a listen to some bonus content as Julie Hubert offers incredible insight through her journey navigating the healthy and unhealthy parts of being an Enneagram 2, known as "The Helper". If you know or are an Enneagram 2 personality type, I highly recommend!

Join me , Amy Vallejo, for a heavy and personal story sharing our journey through struggle-most specifically how a brain tumor 9 years ago changed how I do life. Hear how God, joy, love, tiny miracles, faithfulness, friends, prayer, community, and a glorious 8oz filet, extra dirty martini, loaded baked potato and bananas foster at El Guacho showed up in the midst of it all. El Guacho has become a fancy remembrance stone in my story, a beautiful milestone where we intentionally remember the blessings that we have, the air that we breathe, the people who surround us and the provision of God in the face of adversity. My story matters. It goes well beyond me. Your story matters. It goes well beyond you. Perhaps some of my story resonates, or gives you voice to share yours so others can be blessed.

This episode covers meningioma!

In this episode I cover brain tumours.If you want to follow along with written notes on brain tumours go to https://zerotofinals.com/medicine/neurology/braintumours/ or the neurology section in the Zero to Finals medicine book.This episode covers pathophysiology, presentation, types, diagnosis and management of brain tumours.The audio in the episode was expertly edited by Harry Watchman.

Meningiomas are usually benign tumors of the lining of the brain and spinal cord. While they are typically asymptomatic, they can cause symptoms and be dangerous in certain cases. New DNA research is revealing a hereditary factor in about half of them. Here is what you need to know about getting your DNA tested… Show Notes: https://ancestralfindings.com/meningioma-and-dna-heredity/ Listen to the Weekly Podcast: https://ancestralfindings.com/podcast Weekly Giveaways: https://ancestralfindings.com/drawing  Free eBooks: https://ancestralfindings.com/ebooks  Hard To Find Surnames: https://ancestralfindings.com/surnames  Social Media: https://www.twitter.com/ancestralstuff  https://www.facebook.com/AncestralFindings https://www.instagram.com/ancestralfindings  #Meningioma #DNA #AncestralFindings

Caroline Lee, a self-identity and self-care coach, lived her entire adult life with four Meningioma brain tumors and speaks out about the experience of grieving for your own life. She shares her deep insights and advice for others. You can find her online at www.acaredforheart.com and on IG @acaredforheart.

Hannah Derwent is a mum of two young children when she had to undergo brain surgery to manage a benign meningioma that was growing in her brain stem. The post 71. Living with Inoperable Meningioma – Hannah Derwent appeared first on Recovery After Stroke.

Hannah Derwent is a mum of two young children when she had to undergo brain surgery to manage a benign meningioma that was growing in her brain stem. The post 71. Living with Inoperable Meningioma – Hannah Derwent appeared first on Recovery After Stroke.

Sarah Collins shares her personal experience when she was diagnosed with a Meningioma. Sarah has been a professional singer for most of her life and had no warning that she had a Satsuma sized tumour sitting in her brain. Here is her story.. Don't forget to check out the Aunty M Brain Tumours Website. Follow Aunty M Brain Tumours on: Twitter Facebook Instagram YouTube Pinterest (This Recording was held at Croydon Radio as a part of the Brain Tumour Thursday Show, Dates between 2013 and 2016)

Melinda D’abbenigno shared her experience when she was diagnosed with a brain tumour and how without her faith she couldn't have coped. Don't forget to check out the Aunty M Brain Tumours Website. (This Recording was held at Croydon Radio as a part of the Brain Tumour Thursday Show, Dates between 2013 and 2016)

A tad dramatic?...Absolutely not at all. Driven by a need for few more guaranteed breaths of life. Two almost terminal conditions resolved by doing something unimaginable from their experience. I was interviewed by a radio station (naturopathic content program) to disclose why we are so driven and passionate about the Ketogenic diet or way of living. This is our story. A candid open disclosure, which has apparently received a lot of attention. There are some definite transferable lessons here for many people suffering from “chronic” and over medicated conditions.Got questions…. Send them in. We got answers. Simply email me at drgoldkamp@ketonaturopath.comBuy C8Keto MCT Oil on AmazonOur Facebook Group Keto NaturopathUntil next time, Dr. Karl

In this episode of Cancer Newsline we discuss meningioma, a benign brain tumor that can cause side effects ranging from decreased hearing to problems with mobility.